RELATED CONTENT
NEWS
- Eisai plans EU filing for zonisamide first-line monotherapy
- BioLineRx licenses compound for neuropathic and inflammatory pain
- Xiaflex for Dupuytren's positive in pilot using convenient multiple injections
- Pops: merger will "transform" Alkermes-EDT into "fully integrated company"

